EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, CurveBeam AI's enterprise value is A$63.60 Mil.
CurveBeam AI's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$-11.46 Mil. Therefore, CurveBeam AI's EV-to-EBITDA for today is -5.55.
The historical rank and industry rank for CurveBeam AI's EV-to-EBITDA or its related term are showing as below:
ASX:CVB'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -5.55 Med: -0.64 Max: -0.44
Current: -5.55
During the past 3 years, the highest EV-to-EBITDA of CurveBeam AI was -0.44. The lowest was -5.55. And the median was -0.64.
ASX:CVB's EV-to-EBITDA is ranked worse than 100% of 483
companies
in the Medical Devices & Instruments industry
Industry Median: 15.89
vs ASX:CVB: -5.55
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
CurveBeam AI EV-to-EBITDA Historical Data
The historical data trend for CurveBeam AI's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
CurveBeam AI EV-to-EBITDA Chart
CurveBeam AI Annual Data
Trend
Jun21
Jun22
Jun23
EV-to-EBITDA
-
-
-
CurveBeam AI Semi-Annual Data
Jun21
Dec21
Jun22
Jun23
Dec23
EV-to-EBITDA
-
-
-
-
-
Competitive Comparison of CurveBeam AI's EV-to-EBITDA
For the Medical Devices subindustry, CurveBeam AI's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CurveBeam AI's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CurveBeam AI's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where CurveBeam AI's EV-to-EBITDA falls into.
CurveBeam AI EV-to-EBITDA Calculation
CurveBeam AI's EV-to-EBITDA for today is calculated as:
CurveBeam AI's current Enterprise Value is A$63.60 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. CurveBeam AI's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$-11.46 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CurveBeam AI (ASX:CVB) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
CurveBeam AI's PE Ratio for today is calculated as:
CurveBeam AI's share price for today is A$0.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. CurveBeam AI's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.056.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of CurveBeam AI's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the Company's CT devices to assist in the clinical assessment and management of musculoskeletal health conditions, with a focus on orthopedic and bone health issues. The Company is the first to market with natural bilateral weight-bearing and non-weight-bearing CT, point-of-care imaging equipment with targeted proprietary AI solutions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:CVB has been successfully added to your